Skip to main content
. 2015 Mar 31;2015(3):CD009596. doi: 10.1002/14651858.CD009596.pub4

2008‐002273‐12.

Trial name or title Long term opioid administration in oncologic chronic pain: open label, prospective study on efficacy, safety and pharmacogenetic factors.
Methods Randomised, parallel‐group, open controlled trial.
Participants Inclusion criteria:
  • Age > 18 years.

  • Oncologic, chronic, neuropathic or nociceptive peripheric pain or both.


Exclusion criteria:
  • Abuse history.

  • Opioid analgesic use history.

  • Opioid allergies.

Interventions
  • Morphine (oral solution)

  • Morphine (oral tablet)

  • Oxycodone (oral tablet)

  • Fentanyl (TD patch)

  • Buprenorphine (TD patch)

  • Hydromorphone (prolonged‐release oral tablet)

Outcomes Pain reduction at least 40% in VAS scale.
Starting date Not reported.
Contact information Location: Italy.
Sponsors: Ospedale Policlinico S. Matteo.
Principal investigators: Not reported.
Notes Target enrolment: N = 320.
Study completion date: Unknown but of 3‐year duration.
Other study ID numbers: None reported, but is it the same as NCT00916890 below?